688639 华恒生物
盘后交易 10-14 15:00:00
资讯
新帖
简况
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》
证券之星 · 03:24
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》
华恒生物（688639）10月12日主力资金净买入465.34万元
证券之星 · 10-13 08:34
华恒生物（688639）10月12日主力资金净买入465.34万元
华恒生物（688639）10月9日主力资金净买入1948.00万元
证券之星 · 10-10
华恒生物（688639）10月9日主力资金净买入1948.00万元
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司第五届董事会第九次会议决议公告》
证券之星 · 10-08
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司第五届董事会第九次会议决议公告》
华恒生物：关于召开2026年第一次临时股东会的通知
同花顺 · 09-29
华恒生物：关于召开2026年第一次临时股东会的通知
华恒生物：第五届董事会第九次会议决议公告
同花顺 · 09-29
华恒生物：第五届董事会第九次会议决议公告
华恒生物(688639.SH)拟推2026年限制性股票激励计划
智通财经 · 09-29
华恒生物(688639.SH)拟推2026年限制性股票激励计划
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-14
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
每周股票复盘：华恒生物（688639）实控人被刑拘辞职但公司经营正常
证券之星 · 09-13
每周股票复盘：华恒生物（688639）实控人被刑拘辞职但公司经营正常
华恒生物（688639）披露2026年半年度业绩说明会公告，9月11日股价下跌4.1%
证券之星 · 09-11
华恒生物（688639）披露2026年半年度业绩说明会公告，9月11日股价下跌4.1%
华恒生物：公司将于9月22日召开2026年半年度业绩说明会
证券日报 · 09-11
华恒生物：公司将于9月22日召开2026年半年度业绩说明会
华恒生物获得发明专利授权：“一种α-氨基酸酯酰基转移酶及缬色二肽的生产方法”
证券之星 · 09-11
华恒生物获得发明专利授权：“一种α-氨基酸酯酰基转移酶及缬色二肽的生产方法”
华恒生物(688639)6月30日股东户数1.45万户，较上期增加12.84%
证券之星 · 08-25
华恒生物(688639)6月30日股东户数1.45万户，较上期增加12.84%
图解华恒生物中报：第二季度单季净利润同比下降7.89%
证券之星 · 08-25
图解华恒生物中报：第二季度单季净利润同比下降7.89%
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于重大事项进展的公告》
证券之星 · 08-03
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于重大事项进展的公告》
每周股票复盘：华恒生物（688639）实控人被批捕但称与公司经营无关
证券之星 · 08-02
每周股票复盘：华恒生物（688639）实控人被批捕但称与公司经营无关
华恒生物（688639）披露实际控制人被批准逮捕事项，7月31日股价下跌0.18%
证券之星 · 07-31
华恒生物（688639）披露实际控制人被批准逮捕事项，7月31日股价下跌0.18%
688639实控人，郭恒华被逮捕
市场资讯 · 07-31
688639实控人，郭恒华被逮捕
华恒生物(688639.SH)：实控人郭恒华因涉嫌非法吸收公众存款罪被检察机关批准逮捕
智通财经 · 07-31
华恒生物(688639.SH)：实控人郭恒华因涉嫌非法吸收公众存款罪被检察机关批准逮捕
每周股票复盘：华恒生物（688639）发布2025年度ESG报告摘要
证券之星 · 07-19
每周股票复盘：华恒生物（688639）发布2025年度ESG报告摘要
暂无数据
公司概况
公司名称：
安徽华恒生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2021-04-22
主营业务：
安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是丙氨酸系列、L-缬氨酸、色氨酸、精氨酸、D-泛酸钙、D-泛醇、肌醇、生物基新材料单体、熊果苷。
发行价格：
23.16
{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":17.78,"timestamp":1791961200000,"preClose":18.24,"halted":0,"volume":4950404,"delay":0,"changeRate":-0.0252,"floatShares":250000000,"shares":250000000,"eps":0.4733,"marketStatus":"盘后交易","change":-0.46,"latestTime":"10-14 15:00:00","open":18.21,"high":18.25,"low":17.77,"amount":88587600,"amplitude":0.0263,"askPrice":17.8,"askSize":107,"bidPrice":17.78,"bidSize":545,"shortable":0,"etf":0,"ttmEps":0.4733,"tradingStatus":3,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":4,"adr":0,"adjPreClose":18.24,"symbolType":"stock_kcb","openAndCloseTimeList":[[1791941400000,1791948600000],[1791954000000,1791961200000]],"highLimit":20.06,"lowLimit":16.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":250115693,"isCdr":false,"pbRate":1.64,"roa":"--","peRate":37.566026,"roe":"3.74%","epsLYR":0.53,"committee":0.346369,"marketValue":4447000000,"turnoverRate":0.0198,"status":1,"afterMarket":{"amount":0,"volume":0,"close":17.78,"buyVolume":300,"sellVolume":0,"time":1791962964746,"indexStatus":"盘后交易 10-14 15:29:24","preClose":18.24},"floatMarketCap":4447000000},"requestUrl":"/m/hq/s/688639/tweets","defaultTab":"tweets","newsList":[{"id":"2675364164","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675364164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675364164?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:24","pubTimestamp":1791919459,"startTime":"0","endTime":"0","summary":"公司公告汇总安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见安徽华恒生物科技股份有限公司于2026年9月29日审议通过《2026年限制性股票激励计划（草案）》及相关议案，并于2026年9月30日至10月9日在公司内部公示首次授予激励对象名单，公示期未收到异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400003498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675386236","title":"华恒生物（688639）10月12日主力资金净买入465.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675386236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675386236?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:34","pubTimestamp":1791851653,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，华恒生物报收于18.43元，下跌4.71%，换手率3.47%，成交量8.67万手，成交额1.63亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入1474.98万元，融资偿还1360.13万元，融资净买入114.85万元，连续3日净买入累计1262.73万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300007220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674860329","title":"华恒生物（688639）10月9日主力资金净买入1948.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674860329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674860329?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:20","pubTimestamp":1791591629,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，华恒生物报收于19.34元，上涨3.09%，换手率3.86%，成交量9.66万手，成交额1.83亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入2491.15万元，融资偿还1402.62万元，融资净买入1088.53万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673012796","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司第五届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673012796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673012796?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:30","pubTimestamp":1791397832,"startTime":"0","endTime":"0","summary":"安徽华恒生物科技股份有限公司2026年限制性股票激励计划实施考核管理办法本办法用于保障2026年限制性股票激励计划顺利实施。安徽华恒生物科技股份有限公司2026年限制性股票激励计划首次授予激励对象名单公司公布2026年限制性股票激励计划首次授予激励对象名单，含第一类和第二类限制性股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671349217","title":"华恒生物：关于召开2026年第一次临时股东会的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2671349217","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671349217?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:13","pubTimestamp":1790687580,"startTime":"0","endTime":"0","summary":" 证券日报网讯 9月29日，华恒生物发布公告称，公司将于2026年10月19日召开2026年第一次临时股东会。 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680379312.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680379312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217344","title":"华恒生物：第五届董事会第九次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217344","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671217344?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:13","pubTimestamp":1790687580,"startTime":"0","endTime":"0","summary":" 证券日报网讯 9月29日，华恒生物发布公告称，公司于2026年9月29日召开第五届董事会第九次会议，审议通过《关于提请股东会授权董事会办理股权激励相关事宜的议 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680379313.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680379313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216739","title":"华恒生物(688639.SH)拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216739","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671216739?lang=zh_cn&edition=full","pubTime":"2026-09-29 19:20","pubTimestamp":1790680856,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布2026年限制性股票激励计划(草案)，拟向激励对象授予权益总计1,232.37万股，约占激励计划草案公告时公司股本总额的4.93%。其中首次授予1,055.90万股，预留176.47万股。激励计划第一类限制性股票和第二类限制性股票(含预留)的授予价格为10.69元/股。第一类限制性股票激励计划的有效期为自第一类限制性股票授予登记完成之日起至全部第一类限制性股票解除限售或回购注销完毕之日止，最长不超过48个月;第二类限制性股票激励计划的有效期为自第二类限制性股票首次授予之日起至全部第二类限制性股票归属或作废失效之日止，最长不超过48个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638305","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638305","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638305?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:09","pubTimestamp":1789326552,"startTime":"0","endTime":"0","summary":"公司公告汇总：华恒生物将于9月22日召开2026年半年度业绩说明会，董事长樊义等高管将出席。兴业证券股份有限公司关于安徽华恒生物科技股份有限公司2026年半年度持续督导跟踪报告兴业证券作为保荐机构，对华恒生物2026年上半年持续督导情况进行报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650053","title":"每周股票复盘：华恒生物（688639）实控人被刑拘辞职但公司经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650053","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667650053?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:09","pubTimestamp":1789240151,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，华恒生物报收于16.62元，较上周的17.7元下跌6.1%。本周，华恒生物9月9日盘中最高价报18.63元。公司公告汇总：华恒生物将于2026年09月22日召开2026年半年度业绩说明会，介绍经营成果及财务状况。兴业证券股份有限公司发布关于安徽华恒生物科技股份有限公司2026年半年度持续督导跟踪报告。实际控制人郭恒华因涉嫌非法吸收公众存款被刑事拘留并辞职，案件与公司经营无关，公司已选举新任董事长及总经理，经营正常。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666457857","title":"华恒生物（688639）披露2026年半年度业绩说明会公告，9月11日股价下跌4.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666457857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666457857?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:29","pubTimestamp":1789136989,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，华恒生物报收于16.62元，较前一交易日下跌4.1%，最新总市值为41.57亿元。该股当日开盘17.25元，最高17.25元，最低16.51元，成交额达9052万元，换手率为2.17%。公告显示，公司将于2026年09月22日10:00-11:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司半年度经营成果及财务状况。投资者可于2026年09月15日至09月21日通过上证路演中心或公司邮箱ahb@ehuaheng.com提前提问。说明会后可通过上证路演中心查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666422527","title":"华恒生物：公司将于9月22日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2666422527","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666422527?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:54","pubTimestamp":1789131240,"startTime":"0","endTime":"0","summary":"9月11日，华恒生物发布公告称，公司计划于2026年9月22日10：00-11：00举行2026年半年度业绩说明会。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-11/doc-inirnnxt2109720.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-11/doc-inirnnxt2109720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518001","title":"华恒生物获得发明专利授权：“一种α-氨基酸酯酰基转移酶及缬色二肽的生产方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666518001?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:33","pubTimestamp":1789068803,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示华恒生物新获得一项发明专利授权，专利名为“一种α-氨基酸酯酰基转移酶及缬色二肽的生产方法”，专利申请号为CN202610362573.1，授权日为2026年8月28日。该α氨基酸酯酰基转移酶的氨基酸序列如SEQ ID NO.4所示。今年以来华恒生物新获得专利授权5个，较去年同期减少了64.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100006193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662617738","title":"华恒生物(688639)6月30日股东户数1.45万户，较上期增加12.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662617738","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662617738?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:41","pubTimestamp":1787650913,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华恒生物披露，截至2026年6月30日公司股东户数为1.45万户，较3月31日增加1648.0户，增幅为12.84%。在化学制品行业个股中，华恒生物股东户数低于行业平均水平，截至6月30日，化学制品行业平均股东户数为2.97万户。从股价来看，2026年3月31日至2026年6月30日，华恒生物区间跌幅为42.76%，在此期间股东户数增加1648.0户，增幅为12.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108203","title":"图解华恒生物中报：第二季度单季净利润同比下降7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662108203?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:31","pubTimestamp":1787596295,"startTime":"0","endTime":"0","summary":"证券之星消息，华恒生物2026年中报显示，上半年度公司主营收入16.32亿元，同比上升9.61%；归母净利润1.01亿元，同比下降12.22%；扣非净利润9640.55万元，同比下降15.99%；其中2026年第二季度，公司单季度主营收入8.61亿元，同比上升7.34%；单季度归母净利润5876.04万元，同比下降7.89%；单季度扣非净利润5428.02万元，同比下降15.25%；负债率56.32%，投资收益179.15万元，财务费用3910.62万元，毛利率23.59%。财报数据概要请见下图:本文数据来源于华恒生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656348782","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于重大事项进展的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656348782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656348782?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:50","pubTimestamp":1785693021,"startTime":"0","endTime":"0","summary":"公司公告汇总安徽华恒生物科技股份有限公司关于重大事项进展的公告安徽华恒生物科技股份有限公司于2026年8月1日发布公告，公司实际控制人郭恒华女士因涉嫌非法吸收公众存款罪，已于2026年7月31日被检察机关批准逮捕。郭恒华女士目前未在公司担任董事或高级管理人员职务，前述事项与公司经营无关，不会对公司日常经营活动产生重大不利影响。公司将持续关注事项进展并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656141316","title":"每周股票复盘：华恒生物（688639）实控人被批捕但称与公司经营无关","url":"https://stock-news.laohu8.com/highlight/detail?id=2656141316","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656141316?lang=zh_cn&edition=full","pubTime":"2026-08-02 02:12","pubTimestamp":1785607933,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，华恒生物报收于17.0元，较上周的15.46元上涨9.96%。本周，华恒生物7月30日盘中最高价报17.56元。华恒生物当前最新总市值42.52亿元，在化学制品板块市值排名83/171，在两市A股市值排名3364/5202。郭恒华女士目前未在公司担任董事或高级管理人员职务，前述事项与公司经营无关，不会对公司日常经营活动产生重大不利影响。公司经营管理由高管团队正常推进，业务正常开展。公司将持续关注事项进展并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655362959","title":"华恒生物（688639）披露实际控制人被批准逮捕事项，7月31日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655362959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655362959?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:16","pubTimestamp":1785507386,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，华恒生物报收于17.0元，较前一交易日下跌0.18%，最新总市值为42.52亿元。该股当日开盘16.8元，最高17.29元，最低16.8元，成交额达9538.01万元，换手率为2.24%。近日，安徽华恒生物科技股份有限公司发布公告称，公司实际控制人郭恒华女士因涉嫌非法吸收公众存款罪，已于2026年7月31日被检察机关批准逮捕。郭恒华女士目前未在公司担任董事或高级管理人员职务，前述事项与公司经营无关，不会对公司日常经营活动产生重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100041776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655364018","title":"688639实控人，郭恒华被逮捕","url":"https://stock-news.laohu8.com/highlight/detail?id=2655364018","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655364018?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:38","pubTimestamp":1785505080,"startTime":"0","endTime":"0","summary":"6月24日，华恒生物从郭恒华家属方面获悉，郭恒华因涉嫌非法吸收公众存款罪被公安机关刑事拘留，但调查事项与华恒生物的经营无关。华恒生物公告称，目前，郭恒华未在公司担任董事或高管职务。2026年第一季度，华恒生物的归母净利润同比下降17.61%至4209.73万元，扣非净利润同比下降16.92%至4212.53万元。截至7月31日收盘，华恒生物股价报17元/股，总市值为42.52亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-07-31/doc-iniktkax0849424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655636908","title":"华恒生物(688639.SH)：实控人郭恒华因涉嫌非法吸收公众存款罪被检察机关批准逮捕","url":"https://stock-news.laohu8.com/highlight/detail?id=2655636908","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655636908?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:58","pubTimestamp":1785502715,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)公告，先前公告披露，郭恒华因涉嫌非法吸收公众存款罪被公安机关刑事拘留，并告知调查事项与公司经营无关。公司于2026年7月31日收到公司实际控制人郭恒华家属通知，郭恒华因涉嫌非法吸收公众存款罪被检察机关批准逮捕。据悉，郭恒华目前未在公司担任董事或高级管理人员职务，上述事项不会对公司日常经营活动产生重大不利影响。公司各项经营管理工作由高管团队负责，且有明确的流程保障，公司董事及高级管理人员目前均正常履职。目前，公司业务正常开展，经营活动正常进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"华恒生物(688639.SH)：实控人郭恒华因涉嫌非法吸收公众存款罪被检察机关批准逮捕","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652875258","title":"每周股票复盘：华恒生物（688639）发布2025年度ESG报告摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2652875258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652875258?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:26","pubTimestamp":1784402770,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，华恒生物报收于16.14元，较上周的16.41元下跌1.65%。本周，华恒生物7月15日盘中最高价报17.7元。报告时间范围为2025年1月1日至12月31日，编制依据包括上交所可持续发展报告指引及相关国际标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900001220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229","159717"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791962968333,"stockEarnings":[{"period":"1week","weight":-0.0455},{"period":"1month","weight":0.0975},{"period":"3month","weight":0.0423},{"period":"6month","weight":-0.3583},{"period":"1year","weight":-0.4764},{"period":"ytd","weight":-0.4369}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"14485人(较上一季度增加12.84%)","perCapita":"17267股","listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","registeredCapital":"25011万元","survey":" 安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是丙氨酸系列、L-缬氨酸、色氨酸、精氨酸、D-泛酸钙、D-泛醇、肌醇、生物基新材料单体、熊果苷。","listedPrice":23.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}